GPX8 and colitis: Treatment with NAC, a potent antioxidant, or with VX‐765, a caspase‐4 inhibitor, consistently suppressed caspase 4/11‐dependent inflammasome activation and reduced colitis severity in Gpx8‐deficient mice.